Immunodiagnostics Market Key Players and Growth Outlook

The global immunodiagnostics market, valued at $19.1 billion in 2023, is projected to reach $70.9 billion by 2034, growing at a CAGR of 12.84%. Techniques like ELISA, radioimmunoassay, and lateral flow assays are driving growth by enabling the detection of infectious diseases, autoimmune disorders, allergies, and cancer.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5342

Market Overview

The immunodiagnostics market is growing rapidly, driven by advancements in techniques like ELISA, CLIA, and fluorescent immunoassays, which enable accurate disease detection through antigen-antibody interactions. Hospitals and research labs depend on reagents, enzymes, and chemical components for large-scale testing.

The National Institute of Biologicals ensures quality control of test kits for ELISA, HIV, and other diagnostics, with regulatory support from bodies like CDSCO and the National AIDS Control Organization.

Regional Insights

North America dominated the immunodiagnostics market in 2023, driven by its aging population, rising cases of chronic and infectious diseases, and the growing use of immunodiagnostic tests for early disease detection. Organizations like the National Center for Immunization and Respiratory Diseases (NCIRD) play a key role in managing vaccine-preventable diseases and improving public health. Their divisions focus on bacterial, viral, and respiratory diseases, as well as influenza and coronavirus prevention. Initiatives like funding immunization systems and research programs further strengthen this region’s leadership in healthcare advancements.

In April 2024, AstraZeneca reported 19% revenue growth for the first quarter and announced a 7% annual dividend increase. Similarly, the International Union of Immunology Societies (IUIS) continues to standardize immunology testing through its Quality Assessment and Standardization (QAS) Committee, tackling challenges in clinical research and laboratory testing.

Asia Pacific is emerging as the fastest-growing region in the immunodiagnostics market. Improved healthcare infrastructure, increased investments, and rising health awareness are driving progress. Companies like Roche are advancing personalized medicine, with innovations such as Itovebi, approved by the USFDA for reducing death risks in advanced breast cancer cases. The region also benefits from government efforts, such as India’s National Centre for Disease Control, aimed at controlling communicable diseases.

In 2024, Roche Diagnostics reported a 5% increase in its diagnostics sales, driven by an 8% rise in demand for immunodiagnostics and molecular solutions. Meanwhile, Singapore’s government announced a $222 million investment in quantum technology, boosting healthcare innovation.

Segmental Insights

• By Product: The reagents and consumables segment leads the market, thanks to high demand for reliable, single-use lab products. Companies like QIAGEN and Thermo Fisher Scientific provide high-quality reagents, enzymes, and chemicals that support accurate testing with features like long-term storage and optimal performance conditions.
• By Technology: Enzyme-linked immunosorbent assay (ELISA) remains a standout technology, particularly for its role in detecting COVID-19 cases. Its precise antigen-antibody interaction ensures reliable disease diagnosis.
• By Application: Oncology and endocrinology dominate the market, bolstered by advanced testing methods and personalized treatment options. Innovations in AI and quantum computing have revolutionized cancer care, while molecular assays are improving endocrine disease diagnostics.
• By End-User: Clinical laboratories are set to grow rapidly as more patients prefer faster, accurate testing outside traditional hospital settings. Blood screening tests offer immediate results, enabling timely treatment and tailored medical advice.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/immunodiagnostics-market-sizing

Access exclusive insight now @ https://www.towardshealthcare.com/price/5342

We’ve prepared a service to support you. Please feel free to contact us at  sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare